{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:56:57Z","timestamp":1792796217257,"version":"4.5.0"},"reference-count":66,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Immediate hypersensitivity reactions can pose a clinical and diagnostic challenge, mainly because of\nthe multifarious clinical presentation and distinct underlying \u2013 frequently uncertain \u2013 mechanisms. Anaphylaxis\nencompasses all rapidly developing and life-threatening signs and may cause death. Evidence has accumulated\nthat immediate hypersensitivity and anaphylaxis do not necessarily involve an allergen-specific immune response with cross-linking of specific IgE (sIgE) antibodies bound to their high-affinity IgE receptor (Fc\u03b5RI) on\nthe surface of mast cells (MCs) and basophils. Immediate hypersensitive and anaphylaxis can also result from\nalternative specific and nonspecific MC and basophils activation and degranulation, such as complementderived anaphylatoxins and off-target occupancy of MC and\/or basophil surface receptors such as the Masrelated G protein-coupled receptor X2 (MRGPRX2). Degranulation of MCs and basophils results in the release\nof inflammatory mediators, which can be, depending on the underlying trigger, in a different spatiotemporal\nmanner. In addition, hypersensitivity and anaphylaxis can occur entirely independently of MC and basophil\ndegranulation, as observed in hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) that divert\nnormal arachidonic acid metabolism by inhibiting the cyclooxygenase (COX)-1 isoenzyme. Finally, one should\nremember that anaphylaxis might be part of the phenotype of particular - sometimes poorly recognizable - conditions such as clonal MC diseases (e.g. mastocytosis) and MC activation syndrome (MCAS). This review provides a status update on the molecular mechanisms involved in both sIgE\/Fc\u03b5RI- and non-sIgE\/Fc\u03b5RIdependent immediate hypersensitivity and anaphylaxis. In conclusion, there is increasing evidence for alternative pathophysiological hypersensitivity and anaphylaxis endotypes that are phenotypically and biologically indistinguishable, which are frequently difficult to diagnose, mainly because of uncertainties associated with diagnostic tests that might not enable to unveil the underlying mechanism.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612829666221025091827","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T04:30:15Z","timestamp":1666758615000},"page":"178-184","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Recent Knowledge and Insights on the Mechanisms of Immediate Hypersensitivity\nand Anaphylaxis: IgE\/Fc\u03b5RI- and Non-IgE\/Fc\u03b5RI-Dependent Anaphylaxis"],"prefix":"10.2174","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0672-7529","authenticated-orcid":true,"given":"Didier G.","family":"Ebo","sequence":"first","affiliation":[{"name":"Department of Immunology, Allergology and Rheumatology and the Infla-Med Centre of Excellence, University Antwerp, Antwerp\nUniversity Hospital, Antwerpen, Belgium"},{"name":"Department of Immunology and Allergology, AZ Jan Palfijn Gent, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5571-9501","authenticated-orcid":true,"given":"Michiel","family":"Beyens","sequence":"additional","affiliation":[{"name":"Department of Immunology, Allergology and Rheumatology and the Infla-Med Centre of Excellence, University Antwerp, Antwerp\nUniversity Hospital, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1529-5836","authenticated-orcid":true,"given":"Kevin","family":"Heremans","sequence":"additional","affiliation":[{"name":"Department of Immunology, Allergology and Rheumatology and the Infla-Med Centre of Excellence, University Antwerp, Antwerp\nUniversity Hospital, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-3339","authenticated-orcid":true,"given":"Marie-Line M.","family":"van der Poorten","sequence":"additional","affiliation":[{"name":"Department of Immunology, Allergology and Rheumatology and the Infla-Med Centre of Excellence, University Antwerp, Antwerp\nUniversity Hospital, Antwerpen, Belgium"},{"name":"Department of Paediatrics and the Infla-Med Centre of Excellence, University Antwerp, Antwerp University Hospital, Antwerpen,\nBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1657-5135","authenticated-orcid":true,"given":"Athina L.","family":"Van Gasse","sequence":"additional","affiliation":[{"name":"Department of Immunology, Allergology and Rheumatology and the Infla-Med Centre of Excellence, University Antwerp, Antwerp\nUniversity Hospital, Antwerpen, Belgium"},{"name":"Department of Paediatrics and the Infla-Med Centre of Excellence, University Antwerp, Antwerp University Hospital, Antwerpen,\nBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-0771","authenticated-orcid":true,"given":"Christel","family":"Mertens","sequence":"additional","affiliation":[{"name":"Department of Immunology, Allergology and Rheumatology and the Infla-Med Centre of Excellence, University Antwerp, Antwerp\nUniversity Hospital, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9510-6961","authenticated-orcid":true,"given":"Michel Van","family":"Houdt","sequence":"additional","affiliation":[{"name":"Department of Immunology, Allergology and Rheumatology and the Infla-Med Centre of Excellence, University Antwerp, Antwerp\nUniversity Hospital, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-314X","authenticated-orcid":true,"given":"Vito","family":"Sabato","sequence":"additional","affiliation":[{"name":"Department of Immunology, Allergology and Rheumatology and the Infla-Med Centre of Excellence, University Antwerp, Antwerp\nUniversity Hospital, Antwerpen, Belgium"},{"name":"Department of Immunology and Allergology, AZ Jan Palfijn Gent, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3506-8200","authenticated-orcid":true,"given":"Jessy","family":"Elst","sequence":"additional","affiliation":[{"name":"Department of Immunology, Allergology and Rheumatology and the Infla-Med Centre of Excellence, University Antwerp, Antwerp\nUniversity Hospital, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1034\/j.1398-9995.2001.t01-1-00001.x","volume":"56","author":"Johansson S.G.O.","year":"2001","unstructured":"Johansson S.G.O.; Hourihane J.O.B.; Bousquet J.; A revised nomenclature for allergy: An eaaci position statement from the EAACI nomenclature task force. Allergy 2001,56(9),813-824","journal-title":"Allergy"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaip.2017.03.026","volume":"5","author":"Castells M.C.","year":"2017","unstructured":"Castells M.C.; Drug allergy: Phenotypes, endotypes, and biomarkers. J Allergy Clin Immunol Pract 2017,5(3),626-627","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","volume":"13","author":"Cardona V.","year":"2020","unstructured":"Cardona V.; Ansotegui I.J.; Ebisawa M.; World allergy organization anaphylaxis guidance 2020. World Allergy Organ J 2020,13(10),100472","journal-title":"World Allergy Organ J"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/j.bja.2019.01.031","volume":"123","author":"Ebo D.G.","year":"2019","unstructured":"Ebo D.G.; Clarke R.C.; Mertes P.M.; Platt P.R.; Sabato V.; Sadleir P.H.M.; Molecular mechanisms and pathophysiology of perioperative hypersensitivity and anaphylaxis: A narrative review. Br J Anaesth 2019,123(1),e38-e49","journal-title":"Br J Anaesth"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1042\/BST20170450","volume":"46","author":"Xu H.","year":"2018","unstructured":"Xu H.; Bin N.R.; Sugita S.; Diverse exocytic pathways for mast cell mediators. Biochem Soc Trans 2018,46(2),235-247","journal-title":"Biochem Soc Trans"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/mnfr.200500272","volume":"50","author":"Knol E.F.","year":"2006","unstructured":"Knol E.F.; Requirements for effective IgE cross-linking on mast cells and basophils. Mol Nutr Food Res 2006,50(7),620-624","journal-title":"Mol Nutr Food Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jaci.2016.02.015","volume":"137","author":"Finkelman F.D.","year":"2016","unstructured":"Finkelman F.D.; Khodoun M.V.; Strait R.; Human IgE-independent systemic anaphylaxis. J Allergy Clin Immunol 2016,137(6),1674-1680","journal-title":"J Allergy Clin Immunol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2017.06.003","volume":"140","author":"Reber L.L.","year":"2017","unstructured":"Reber L.L.; Hernandez J.D.; Galli S.J.; The pathophysiology of anaphylaxis. J Allergy Clin Immunol 2017,140(2),335-348","journal-title":"J Allergy Clin Immunol"},{"key":"ref=9","author":"McLendon K.","year":"2021","unstructured":"McLendon K.; Sternard B.T.;  Anaphylaxis 2021","journal-title":"Anaphylaxis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/j.1572-0241.2003.07457.x","volume":"98","author":"Cheifetz A.","year":"2003","unstructured":"Cheifetz A.; Smedley M.; Martin S.; The incidence and management of infusion reactions to infliximab: A large center experience. Am J Gastroenterol 2003,98(6),1315-1324","journal-title":"Am J Gastroenterol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2036.2011.04682.x","volume":"34","author":"Steenholdt C.","year":"2011","unstructured":"Steenholdt C.; Svenson M.; Bendtzen K.; Thomsen O.&#xD8;.; Brynskov J.; Ainsworth M.A.; Severe infusion reactions to infliximab: Aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2011,34(1),51-58","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.crohns.2011.08.001","volume":"6","author":"Steenholdt C.","year":"2012","unstructured":"Steenholdt C.; Svenson M.; Bendtzen K.; Thomsen O.&#xD8;.; Brynskov J.; Ainsworth M.A.; Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn\u2019s disease. J Crohn\u2019s Colitis 2012,6(1),108-111","journal-title":"J Crohn\u2019s Colitis"},{"key":"ref=13","first-page":"224","volume":"72","author":"Novey H.S.","year":"1994","unstructured":"Novey H.S.; Pahl M.; Haydik I.; Vaziri N.D.; Immunologic studies of anaphylaxis to iron dextran in patients on renal dialysis. Ann Allergy 1994,72(3),224-228","journal-title":"Ann Allergy"},{"key":"ref=14","first-page":"69","volume":"60","author":"Umeda Y.","year":"2007","unstructured":"Umeda Y.; Fukumoto Y.; Miyauchi T.; Anaphylactic shock related to aprotinin induced by anti-aprotinin immunoglobulin G antibody alone; report of a case. Kyobu Geka 2007,60(1),69-71","journal-title":"Kyobu Geka"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1213\/ane.0b013e31817e6043","volume":"107","author":"Kober B.J.","year":"2008","unstructured":"Kober B.J.; Scheule A.M.; Voth V.; Deschner N.; Schmid E.; Ziemer G.; Anaphylactic reaction after systemic application of aprotinin triggered by aprotinin-containing fibrin sealant. Anesth Analg 2008,107(2),406-409","journal-title":"Anesth Analg"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","volume":"358","author":"Kishimoto T.K.","year":"2008","unstructured":"Kishimoto T.K.; Viswanathan K.; Ganguly T.; Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 2008,358(23),2457-2467","journal-title":"N Engl J Med"},{"key":"ref=17","first-page":"89","volume":"29","author":"Arroyave C.M.","year":"1977","unstructured":"Arroyave C.M.; Tan E.M.; Mechanism of complement activation by radiographic contrast media. Clin Exp Immunol 1977,29(1),89-94","journal-title":"Clin Exp Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.bbrc.2006.08.177","volume":"349","author":"Tatemoto K.","year":"2006","unstructured":"Tatemoto K.; Nozaki Y.; Tsuda R.; Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem Biophys Res Commun 2006,349(4),1322-1328","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature14022","volume":"519","author":"McNeil B.D.","year":"2015","unstructured":"McNeil B.D.; Pundir P.; Meeker S.; Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 2015,519(7542),237-241","journal-title":"Nature"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3389\/fimmu.2018.03027","volume":"9","author":"Porebski G.","year":"2018","unstructured":"Porebski G.; Kwiecien K.; Pawica M.; Kwitniewski M.; Mas-Related G.; Mas-related g protein-coupled Receptor-x2 (MRGPRX2) in drug hypersensitivity reactions. Front Immunol 2018,9,3027","journal-title":"Front Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.coi.2021.03.011","volume":"72","author":"Ali H.","year":"2021","unstructured":"Ali H.; Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs. Curr Opin Immunol 2021,72,65-71","journal-title":"Curr Opin Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"676354","DOI":"10.3389\/fimmu.2021.676354","volume":"12","author":"McNeil B.D.","year":"2021","unstructured":"McNeil B.D.; MRGPRX2 and adverse drug reactions. Front Immunol 2021,12,676354","journal-title":"Front Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"01184","DOI":"10.1016\/j.jaci.2022.09.004","volume":"S0091-6749","author":"Kolkhir P","year":"2022","unstructured":"Kolkhir P; Ali H; Babina M; MRGPRX2 in drug allergy: What we know and what we do not know. J Allergy Clin Immunol 2022,S0091-6749(22),01184-8","journal-title":"J Allergy Clin Immunol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.bja.2020.10.006","volume":"126","author":"Ebo D.G.","year":"2021","unstructured":"Ebo D.G.; Van der Poorten M.L.; Elst J.; Immunoglobulin E cross-linking or MRGPRX2 activation: Clinical insights from rocuronium hypersensitivity. Br J Anaesth 2021,126(1),e27-e29","journal-title":"Br J Anaesth"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1213\/01.ANE.0000097168.32472.0D","volume":"98","author":"Blunk J.A.","year":"2004","unstructured":"Blunk J.A.; Schmelz M.; Zeck S.; Skov P.; Likar R.; Koppert W.; Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: An in vivo microdialysis study in human skin. Anesth Analg 2004,98(2),364-370","journal-title":"Anesth Analg"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/all.15270","volume":"77","author":"Babina M.","year":"2022","unstructured":"Babina M.; Wang Z.; Li Z.; Fc&#x3B5;RI\u2010 and MRGPRX2\u2010evoked acute degranulation responses are fully additive in human skin mast cells. Allergy 2022,77(6),1906-1909","journal-title":"Allergy"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jaci.2021.02.013","volume":"147","author":"Bruhns P.","year":"2021","unstructured":"Bruhns P.; Chollet-Martin S.; Mechanisms of human drug-induced anaphylaxis. J Allergy Clin Immunol 2021,147(4),1133-1142","journal-title":"J Allergy Clin Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"eaat1479","DOI":"10.1126\/scitranslmed.aat1479","volume":"11","author":"J&#xF6;nsson F.","year":"2019","unstructured":"J&#xF6;nsson F.; de Chaisemartin L.; Granger V.; An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis. Sci Transl Med 2019,11(500),eaat1479","journal-title":"Sci Transl Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"6784","DOI":"10.2174\/1381612822666160928142814","volume":"22","author":"Dona I.","year":"2017","unstructured":"Dona I.; Salas M.; Perkins J.; Hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Curr Pharm Des 2017,22(45),6784-6802","journal-title":"Curr Pharm Des"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","volume":"135","author":"Nassiri M.","year":"2015","unstructured":"Nassiri M.; Babina M.; D&#xF6;lle S.; Edenharter G.; Ru&#xEB;ff F.; Worm M.; Ramipril and metoprolol intake aggravate human and murine anaphylaxis: Evidence for direct mast cell priming. J Allergy Clin Immunol 2015,135(2),491-499","journal-title":"J Allergy Clin Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000328760","volume":"157","author":"Valent P.","year":"2012","unstructured":"Valent P.; Akin C.; Arock M.; Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal. Int Arch Allergy Immunol 2012,157(3),215-225","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.iac.2014.01.002","volume":"34","author":"Cruse G.","year":"2014","unstructured":"Cruse G.; Metcalfe D.D.; Olivera A.; Functional deregulation of KIT. Immunol Allergy Clin North Am 2014,34(2),219-237","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","volume":"147","author":"Lyons J.J.","year":"2021","unstructured":"Lyons J.J.; Chovanec J.; O\u2019Connell M.P.; Heritable risk for severe anaphylaxis associated with increased &#x3B1;-tryptase\u2013encoding germline copy number at TPSAB1. J Allergy Clin Immunol 2021,147(2),622-632","journal-title":"J Allergy Clin Immunol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1016\/j.jaip.2021.03.050","volume":"9","author":"Ebo D.G.","year":"2021","unstructured":"Ebo D.G.; De Puysseleyr L.P.; Van Gasse A.L.; Mast cell activation during suspected perioperative hypersensitivity: A need for paired samples analysis. J Allergy Clin Immunol Pract 2021,9(8),3051-3059.e1","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1172\/JCI90361","volume":"126","author":"Karhausen J.","year":"2016","unstructured":"Karhausen J.; Abraham S.N.; How mast cells make decisions. J Clin Invest 2016,126(10),3735-3738","journal-title":"J Clin Invest"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1172\/JCI85538","volume":"126","author":"Gaudenzio N.","year":"2016","unstructured":"Gaudenzio N.; Sibilano R.; Marichal T.; Different activation signals induce distinct mast cell degranulation strategies. J Clin Invest 2016,126(10),3981-3998","journal-title":"J Clin Invest"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/cea.14110","volume":"52","author":"Elst J.","year":"2022","unstructured":"Elst J.; van der Poorten M.L.M.; Van Gasse A.L.; Tryptase release does not discriminate between IgE and MRGPRX2\u2010mediated activation in human mast cells. Clin Exp Allergy 2022,52(6),797-800","journal-title":"Clin Exp Allergy"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"668962","DOI":"10.3389\/fimmu.2021.668962","volume":"12","author":"Elst J.","year":"2021","unstructured":"Elst J.; Maurer M.; Sabato V.; Novel insights on MRGPRX2-mediated hypersensitivity to neuromuscular blocking agents and fluoroquinolones. Front Immunol 2021,12,668962","journal-title":"Front Immunol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.jaip.2021.03.011","volume":"9","author":"Vitte J.","year":"2021","unstructured":"Vitte J.; Sabato V.; Tacquard C.; Use and interpretation of acute and baseline tryptase in perioperative hypersensitivity and anaphylaxis. J Allergy Clin Immunol Pract 2021,9(8),2994-3005","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.jaci.2014.06.007","volume":"134","author":"Sabato V.","year":"2014","unstructured":"Sabato V.; Van De Vijver E.; Hagendorens M.; Familial hypertryptasemia with associated mast cell activation syndrome. J Allergy Clin Immunol 2014,134(6),1448-1450.e3","journal-title":"J Allergy Clin Immunol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10875-018-0506-y","volume":"38","author":"Sabato V.","year":"2018","unstructured":"Sabato V.; Chovanec J.; Faber M.; Milner J.D.; Ebo D.; Lyons J.J.; First identification of an inherited tpsab1 quintuplication in a patient with clonal mast cell disease. J Clin Immunol 2018,38(4),457-459","journal-title":"J Clin Immunol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","volume":"38","author":"Lyons J.J.","year":"2018","unstructured":"Lyons J.J.; Hereditary alpha tryptasemia. Immunol Allergy Clin North Am 2018,38(3),483-495","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","volume":"140","author":"Castells M.","year":"2017","unstructured":"Castells M.; Diagnosis and management of anaphylaxis in precision medicine. J Allergy Clin Immunol 2017,140(2),321-333","journal-title":"J Allergy Clin Immunol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/ACI.0000000000000472","volume":"18","author":"Sala-Cunill A.","year":"2018","unstructured":"Sala-Cunill A.; Guilarte M.; Cardona V.; Phenotypes, endotypes and biomarkers in anaphylaxis: Current insights. Curr Opin Allergy Clin Immunol 2018,18(5),370-376","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jaip.2019.08.033","volume":"8","author":"Van Gasse A.L.","year":"2020","unstructured":"Van Gasse A.L.; Ebo D.G.; Faber M.A.; Cross-reactivity in IgE-mediated allergy to cefuroxime: Focus on the R1 side chain. J Allergy Clin Immunol Pract 2020,8(3),1094-1096.e1","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cca.2020.02.005","volume":"504","author":"van der Poorten M.L.M.","year":"2020","unstructured":"van der Poorten M.L.M.; Van Gasse A.L.; Hagendorens M.M.; Serum specific IgE antibodies in immediate drug hypersensitivity. Clin Chim Acta 2020,504,119-124","journal-title":"Clin Chim Acta"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/14737159.2020.1730817","volume":"20","author":"Ebo D.G.","year":"2020","unstructured":"Ebo D.G.; Bridts C.H.; Rihs H.P.; hevea latex-associated allergies: Piecing together the puzzle of the latex IgE reactivity profile. Expert Rev Mol Diagn 2020,20(4),367-373","journal-title":"Expert Rev Mol Diagn"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1600-0536.2006.00924.x","volume":"55","author":"Ebo D.G.","year":"2006","unstructured":"Ebo D.G.; Bridts C.H.; Stevens W.J.; IgE-mediated anaphylaxis from chlorhexidine: Diagnostic possibilities. Contact Dermat 2006,55(5),301-302","journal-title":"Contact Dermat"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1016\/j.jaip.2021.06.016","volume":"9","author":"Elst J.","year":"2021","unstructured":"Elst J.; Moonen N.; van der Poorten M.L.M.; The passively sensitized mast cell activation test is a reliable diagnostic for chlorhexidine allergy. J Allergy Clin Immunol Pract 2021,9(10),3826-3828.e2","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/01.anes.0000270735.40872.f2","volume":"107","author":"Ebo D.G.","year":"2007","unstructured":"Ebo D.G.; Venemalm L.; Bridts C.H.; Immunoglobulin E antibodies to rocuronium: A new diagnostic tool. Anesthesiology 2007,107(2),253-259","journal-title":"Anesthesiology"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/cyto.b.21074","volume":"84B","author":"Leysen J.","year":"2013","unstructured":"Leysen J.; De Witte L.; Sabato V.; IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: Lessons from flow cytometry. Cytometry B Clin Cytom 2013,84B(2),65-70","journal-title":"Cytometry B Clin Cytom"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.anai.2010.12.020","volume":"106","author":"Pinnobphun P.","year":"2011","unstructured":"Pinnobphun P.; Buranapraditkun S.; Kampitak T.; Hirankarn N.; Klaewsongkram J.; The diagnostic value of basophil activation test in patients with an immediate hypersensitivity reaction to radiocontrast media. Ann Allergy Asthma Immunol 2011,106(5),387-393","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1398-9995.2008.01832.x","volume":"64","author":"Brockow K.","year":"2009","unstructured":"Brockow K.; Romano A.; Aberer W.; Skin testing in patients with hypersensitivity reactions to iodinated contrast media - A european multicenter study. Allergy 2009,64(2),234-241","journal-title":"Allergy"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"n\/a","DOI":"10.1111\/all.12214","volume":"68","author":"Salas M","year":"2013","unstructured":"Salas M; Gomez F; Fernandez TD; Diagnosis of immediate hypersensitivity reactions to radiocontrast media. Allergy 2013,68(9),n\/a","journal-title":"Allergy"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.jaip.2018.12.003","volume":"7","author":"Stone C.A.","year":"2019","unstructured":"Stone C.A.; Liu Y.; Relling M.V.; Immediate hypersensitivity to polyethylene glycols and polysorbates: More common than we have recognized. J Allergy Clin Immunol Pract 2019,7(5),1533-1540.e8","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.jaip.2020.11.011","volume":"9","author":"Zhou Z.H.","year":"2021","unstructured":"Zhou Z.H.; Stone C.A.; Jakubovic B.; Anti-PEG IgE in anaphylaxis associated with polyethylene glycol. J Allergy Clin Immunol Pract 2021,9(4),1731-1733.e3","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jaip.2020.09.027","volume":"9","author":"Alvarez-Arango S.","year":"2021","unstructured":"Alvarez-Arango S.; Yerneni S.; Tang O.; Vancomycin hypersensitivity reactions documented in electronic health records. J Allergy Clin Immunol Pract 2021,9(2),906-912","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000453525","volume":"171","author":"Cesana P.","year":"2016","unstructured":"Cesana P.; Scherer K.; Bircher A.J.; Immediate type hypersensitivity to heparins: Two case reports and a review of the literature. Int Arch Allergy Immunol 2016,171(3-4),285-289","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1710-1492-9-1","volume":"9","author":"Anders D.","year":"2013","unstructured":"Anders D.; Trautmann A.; Allergic anaphylaxis due to subcutaneously injected heparin. Allergy Asthma Clin Immunol 2013,9(1),1","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.molimm.2008.08.276","volume":"46","author":"Hamad I.","year":"2008","unstructured":"Hamad I.; Hunter A.C.; Szebeni J.; Moghimi S.M.; Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process. Mol Immunol 2008,46(2),225-232","journal-title":"Mol Immunol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1016\/j.biomaterials.2011.03.035","volume":"32","author":"Merkel OM","year":"2011","unstructured":"Merkel OM; Urbanics R; Bed\u0151cs P; In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers. Biomaterials 2011,32(21),4936-4942","journal-title":"Biomaterials"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"489","DOI":"10.18176\/jiaci.0557","volume":"31","author":"Elst J.","year":"2021","unstructured":"Elst J.; Sabato V.; Faber M.A.; MRGPRX2 and immediate drug hypersensitivity: Insights from cultured human mast cells. J Investig Allergol Clin Immunol 2021,31(6),489-499","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/cells10010156","volume":"10","author":"Chompunud Na Ayudhya C.","year":"2021","unstructured":"Chompunud Na Ayudhya C.; Amponnawarat A.; Roy S.; Oskeritzian C.A.; Ali H.; MRGPRX2 activation by rocuronium: Insights from studies with human skin mast cells and missense variants. Cells 2021,10(1),156","journal-title":"Cells"},{"key":"ref=64","first-page":"10","volume":"206","author":"Fukuoka Y.","year":"2021","unstructured":"Fukuoka Y.; Schwartz D.L.; Ward B.R.; Activation of human skin mast cells by vancomycin via MrgX2: Comparison to the effects of brimonidine. J Immunol 2021,206(23),10-23","journal-title":"J Immunol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/BF03022528","volume":"53","author":"Sarkar P.","year":"2006","unstructured":"Sarkar P.; Nicholson G.; Hall G.; Brief review: Angiotensin converting enzyme inhibitors and angioedema: Anesthetic implications. Can J Anaesth 2006,53(10),994-1003","journal-title":"Can J Anaesth"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/ACO.0b013e328352dda5","volume":"25","author":"Stojiljkovic L.","year":"2012","unstructured":"Stojiljkovic L.; Renin-angiotensin system inhibitors and angioedema. Curr Opin Anaesthesiol 2012,25(3),356-362","journal-title":"Curr Opin Anaesthesiol"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666221025091827","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210344\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666221025091827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T04:17:31Z","timestamp":1679977051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210344\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612829666221025091827","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}